EU regulator rejects Biogen's Alzheimer's drug
Dec 17 (Reuters) - The European Union's drug regulator on Friday rejected Biogen Inc's Alzheimer's drug, Aduhelm, dealing a blow to the U.S. drugmaker...
Dec 17 (Reuters) - The European Union's drug regulator on Friday rejected Biogen Inc's Alzheimer's drug, Aduhelm, dealing a blow to the U.S. drugmaker...